menu
    • menu

    Company profile for Reviva Pharmaceuticals

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Reviva Pharmaceuticals, Inc., (Reviva) headquartered in Santa Clara, California, is a fast growing privately held, late-stage clinical development pharmaceutical company. Reviva is developing a portfolio of internally discovered next generation innovative therapies using chemical genomic driven approaches and proprietary technologies that addresses unmet medical needs in the areas of central nervous system (CNS), cardiovascula...
    Reviva Pharmaceuticals, Inc., (Reviva) headquartered in Santa Clara, California, is a fast growing privately held, late-stage clinical development pharmaceutical company. Reviva is developing a portfolio of internally discovered next generation innovative therapies using chemical genomic driven approaches and proprietary technologies that addresses unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic and inflammatory diseases. The leadership and management team is comprised of highly successful and experienced professionals from the pharmaceutical industry.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Reviva PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    19925 Stevens Creek Blvd., Suite 100 Cupertino, CA 95014
    Telephone
    Telephone
    +1 408 816 1470
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://revivapharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/reviva-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Reviva to Participate in Chat by AGP on Brilaroxazine’s Potential
    Reviva to Participate in Chat by AGP on Brilaroxazine’s Potential

    23 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/23/3279835/0/en/reviva-to-participate-in-a-fireside-chat-hosted-by-a-g-p-on-brilaroxazine-s-potential-across-multiple-neuropsychiatric-indications.html

    GLOBENEWSWIRE
    23 Apr 2026
    Share Share
    Reviva Announces Letter To Shareholders
    Reviva Announces Letter To Shareholders

    15 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7181722

    FIRSTWORD PHARMA
    15 Apr 2026
    Share Share
    Reviva Unveils 2025 Financials & Business Updates
    Reviva Unveils 2025 Financials & Business Updates

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3264432/0/en/Reviva-Reports-Full-Year-2025-Financial-Results-and-Recent-Business-Highlights.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Reviva Pharma Closes $10M Public Offering
    Reviva Pharma Closes $10M Public Offering

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260331/0/en/Reviva-Pharmaceuticals-Holdings-Inc-Announces-Closing-of-10-Million-Public-Offering.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share
    Reviva Pharma Announces Proposed Public Offering
    Reviva Pharma Announces Proposed Public Offering

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3258600/0/en/Reviva-Pharmaceuticals-Holdings-Inc-Announces-Proposed-Public-Offering.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share
    Reviva Shares RECOVER Ph3 Data on Schizophrenia Negative Symptoms
    Reviva Shares RECOVER Ph3 Data on Schizophrenia Negative Symptoms

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215319/0/en/Reviva-Announces-Publication-on-Clinical-Vocal-Biomarker-Data-from-the-RECOVER-Phase-3-Clinical-Trial-of-Brilaroxazine-to-Treat-Negative-Symptoms-in-Schizophrenia.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search